Have a feature idea you'd love to see implemented?
Let us know!
ELAN Elanco Animal Health Inc
Price (delayed)
$13.4
Market cap
$6.62B
P/E Ratio
32.68
Dividend/share
N/A
EPS
$0.41
Enterprise value
$10.49B
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company,
Highlights
The company's EPS has surged by 118% YoY and by 116% QoQ
Elanco Animal Health's net income has soared by 118% YoY and by 116% from the previous quarter
The quick ratio has contracted by 11% YoY and by 2.8% from the previous quarter
The gross margin has contracted by 4.5% YoY
Key stats
What are the main financial stats of ELAN
Market
Valuations
Earnings
Shares outstanding
494.35M
Market cap
$6.62B
Enterprise value
$10.49B
Price to earnings (P/E)
32.68
Price to book (P/B)
1.02
Price to sales (P/S)
1.49
EV/EBIT
15.71
EV/EBITDA
7.85
EV/Sales
2.36
Revenue
$4.45B
EBIT
$668M
EBITDA
$1.34B
Free cash flow
$380M
Per share
Balance sheet
Liquidity
EPS
$0.41
Free cash flow per share
$0.77
Book value per share
$13.2
Revenue per share
$9.01
TBVPS
$9.4
Total assets
$13.28B
Total liabilities
$6.76B
Debt
$4.36B
Equity
$6.52B
Working capital
$2.05B
Debt to equity
0.67
Current ratio
2.55
Quick ratio
1.06
Net debt/EBITDA
2.89
Margins
Efficiency
Dividend
EBITDA margin
30%
Gross margin
54.7%
Net margin
4.6%
Operating margin
0.6%
Return on assets
1.5%
Return on equity
3.3%
Return on invested capital
7.7%
Return on capital employed
5.6%
Return on sales
15%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ELAN stock price
How has the Elanco Animal Health stock price performed over time
Intraday
-0.3%
1 week
-4.56%
1 month
6.18%
1 year
13.75%
YTD
-10.07%
QTD
-8.78%
Financial performance
How have Elanco Animal Health's revenue and profit performed over time
Revenue
$4.45B
Gross profit
$2.44B
Operating income
$28M
Net income
$205M
Gross margin
54.7%
Net margin
4.6%
Elanco Animal Health's net income has soared by 118% YoY and by 116% from the previous quarter
The net margin has soared by 118% year-on-year and by 116% since the previous quarter
The company's operating margin has surged by 103% YoY and by 103% QoQ
Elanco Animal Health's operating income has soared by 103% YoY and by 103% from the previous quarter
Growth
What is Elanco Animal Health's growth rate over time
Valuation
What is Elanco Animal Health stock price valuation
P/E
32.68
P/B
1.02
P/S
1.49
EV/EBIT
15.71
EV/EBITDA
7.85
EV/Sales
2.36
The company's EPS has surged by 118% YoY and by 116% QoQ
The price to book (P/B) is 22% lower than the 5-year quarterly average of 1.3 and 15% lower than the last 4 quarters average of 1.2
ELAN's equity is up by 10% from the previous quarter and by 6% YoY
ELAN's P/S is 40% below its 5-year quarterly average of 2.5 and 12% below its last 4 quarters average of 1.7
Efficiency
How efficient is Elanco Animal Health business performance
Elanco Animal Health's ROIC has soared by 179% YoY and by 173% from the previous quarter
The company's return on sales has surged by 174% YoY and by 169% QoQ
The company's return on assets has surged by 120% YoY and by 117% QoQ
Elanco Animal Health's ROE has soared by 120% YoY and by 116% from the previous quarter
Dividends
What is ELAN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ELAN.
Financial health
How did Elanco Animal Health financials performed over time
Elanco Animal Health's total assets is 96% higher than its total liabilities
The company's total liabilities fell by 18% YoY and by 14% QoQ
Elanco Animal Health's current ratio has decreased by 13% from the previous quarter and by 10% YoY
The debt is 33% smaller than the equity
The debt to equity has declined by 30% since the previous quarter and by 30% year-on-year
The debt is down by 26% year-on-year and by 23% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.